// App-Quantinova.ai

: Real-world treatment and quality of life (QOL) in locally advanced or metastatic urothelial carcinoma (la/mUC) in Saudi Arabia, Singapore, South Korea, Taiwan, and Turkey.

Researchers

Presenter

  • Li-Jen Cheng

Principal Investigators

  • Janet Kim

  • Apurba Mukherjee

  • Neil Milloy

  • Mia Unsworth

  • Daniel Ng

Medical Centers

  • Astellas Pharma Singapore Pte, Ltd., Singapore, Singapore

  • Adelphi Real World, Bollington, United Kingdom

Locations

  • Singapore

  • United Kingdom

  • United States

Companies

  • Astellas Pharma US,

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Advanced Urothelial Carcinoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A